Regeneron Pharmaceuticals, Inc. (REGN)
698.25
-14.62
(-2.05%)
USD |
NASDAQ |
May 15, 16:00
698.50
+0.25
(+0.04%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Assets (Quarterly) : 40.87B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 92.50B |
| AbbVie, Inc. | 136.46B |
| Biogen, Inc. | 29.48B |
| Eli Lilly & Co. | 116.58B |
| Merck & Co., Inc. | 128.68B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.445B |
| Shareholders Equity (Quarterly) | 31.42B |
| Debt to Equity Ratio | 0.0861 |
| Current Ratio | 3.565 |
| Net Debt Paydown Yield | 0.06% |